Email

Positions

Professor

Pediatrics-Hema & Oncology
Baylor College of Medicine
Houston, TX, US

Associate Dean for Research Assurances

Baylor College of Medicine

Co-Director, Texas Children's Cancer Center Developmental Therapeutics Program

Texas Children's Hospital

Member

Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States

Addresses

Texas Children's Hospital, Clinical Care Center (Clinic)

6701 Fannin St
14th floor
Houston, TX, 77030
United States
Phone: (832) 822-4242

Certifications

American Board of Pediatrics

American Board of Pediatrics, Pediatric Hematology and Oncology

American Board of Pediatrics, Hospice and Palliative Medicine

Websites

Selected Publications

• Bomgaars L, Kerr J, Berg S, Kuttesch J, Klenke R, Blaney SM. " A phase I study of irinotecan administered on a weekly schedule in pediatric patients. " Pediatr Blood Cancer. 2006 Jan ; 46 (1) : 50-5.
  Pubmed PMID: 15768380.
• Blaney S, Berg SL, Pratt C, Weitman S, Sullivan J, Luchtman-Jones L, Bernstein M. " A phase I study of irinotecan in pediatric patients: a pediatric oncology group study. " Clin. Cancer Res.. 2001 Jan ; 7 (1) : 32-7.
  Pubmed PMID: 11205914.
• Adamson PC, Balis FM, Belasco JE, Lange B, Berg SL, Blaney SM, Craig C, Poplack DG. " A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer. " Cancer Res.. 1995 Sep 15; 55 (18) : 4069-72.
  Pubmed PMID: 7664282.
• Warren KE, Gururangan S, Geyer JR, McLendon RE, Poussaint TY, Wallace D, Balis FM, Berg SL, Packer RJ, Goldman S, Minturn JE, Pollack IF, Boyett JM, Kun LE. " A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study. " J. Neurooncol.. 2012 Feb ; 106 (3) : 643-9.
  Pubmed PMID: 21968943.
• Beaty O, Berg S, Blaney S, Malogolowkin M, Krailo M, Knight R, Schaiquevich P, Stewart C, Chen Z, Nelson M, Voss S, Ivy SP, Adamson PC. " A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study. " Pediatr Blood Cancer. 2010 Sep ; 55 (3) : 440-5.
  Pubmed PMID: 20658614.
• Horton TM, Berg SL. " Educational paper : The development of new therapies for pediatric oncology. " Eur. J. Pediatr.. 2011 May ; 170 (5) : 555-9.
  Pubmed PMID: 21190039.
• Berg SL. " Ethical challenges in cancer research in children. " Oncologist. 2007 Nov ; 12 (11) : 1336-43.
  Pubmed PMID: 18055854.
• Thompson PA, Rosner GL, Matthay KK, Moore TB, Bomgaars LR, Ellis KJ, Renbarger J, Berg SL. " Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study. " Cancer Chemother. Pharmacol.. 2009 Jul ; 64 (2) : 243-51.
  Pubmed PMID: 19020877.
• Murry DJ, Cherrick I, Salama V, Berg S, Bernstein M, Kuttesch N, Blaney SM. " Influence of phenytoin on the disposition of irinotecan: a case report. " J. Pediatr. Hematol. Oncol.. 2002 Feb ; 24 (2) : 130-3.
  Pubmed PMID: 11990699.
• Kerr JZ, Berg S, Blaney SM. " Intrathecal chemotherapy. " Crit. Rev. Oncol. Hematol.. 2001 Mar ; 37 (3) : 227-36.
  Pubmed PMID: 11248578.
• Berg SL. " When too much is just enough: what do oncologists tell parents? " Pediatr Blood Cancer. 2009 Apr ; 52 (4) : 437-8.
  Pubmed PMID: 19058206.
• Horton TM, Jenkins G, Pati D, Zhang L, Dolan ME, Ribes-Zamora A, Bertuch AA, Blaney SM, Delaney SL, Hegde M, Berg SL. " Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity. " Mol. Cancer Ther.. 2009 Aug ; 8 (8) : 2232-42.
  Pubmed PMID: 19671751.
• Berg SL, Cairo MS, Russell H, Ayello J, Ingle AM, Lau H, Chen N, Adamson PC, Blaney SM. " Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report. " J. Clin. Oncol.. 2011 Jan 20; 29 (3) : 316-23.
  Pubmed PMID: 21149673.
• Horton TM, Gannavarapu A, Blaney SM, D'Argenio DZ, Plon SE, Berg SL. " Bortezomib interactions with chemotherapy agents in acute leukemia in vitro. " Cancer Chemother. Pharmacol.. 2006 Jul ; 58 (1) : 13-23.
  Pubmed PMID: 16292537.
• Kim A, Fox E, Warren K, Blaney SM, Berg SL, Adamson PC, Libucha M, Byrley E, Balis FM, Widemann BC. " Characteristics and outcome of pediatric patients enrolled in phase I oncology trials. " Oncologist. 2008 Jun ; 13 (6) : 679-89.
  Pubmed PMID: 18586923.
• Barbieri E, Mehta P, Chen Z, Zhang L, Slack A, Berg S, Shohet JM. " MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death. " Mol. Cancer Ther.. 2006 Sep ; 5 (9) : 2358-65.
  Pubmed PMID: 16985070.
• Wilson WH, Berg SL, Bryant G, Wittes RE, Bates S, Fojo A, Steinberg SM, Goldspiel BR, Herdt J, O'Shaughnessy J. " Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. " J. Clin. Oncol.. 1994 Aug ; 12 (8) : 1621-9.
  Pubmed PMID: 7913721.
• Adams DM, Zhou T, Berg SL, Bernstein M, Neville K, Blaney SM. " Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children's Oncology Group study. " Pediatr Blood Cancer. 2008 Mar ; 50 (3) : 549-53.
  Pubmed PMID: 17941066.
• Potter SL, Berg S, Ingle AM, Krailo M, Adamson PC, Blaney SM. " Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962). " Pediatr Blood Cancer. 2012 Mar ; 58 (3) : 362-5.
  Pubmed PMID: 21910214.
• Chintagumpala M, Blaney SM, Bomgaars LR, Aleksic A, Kuttesch JF, Klenke RA, Berg SL. " Phase I and pharmacokinetic study of thalidomide with carboplatin in children with cancer. " J. Clin. Oncol.. 2004 Nov 1; 22 (21) : 4394-400.
  Pubmed PMID: 15514381.
• Berg SL, Blaney SM, Devidas M, Lampkin TA, Murgo A, Bernstein M, Billett A, Kurtzberg J, Reaman G, Gaynon P, Whitlock J, Krailo M, Harris MB. " Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group. " J. Clin. Oncol.. 2005 May 20; 23 (15) : 3376-82.
  Pubmed PMID: 15908649.
• Blaney SM, Bernstein M, Neville K, Ginsberg J, Kitchen B, Horton T, Berg SL, Krailo M, Adamson PC. " Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015). " J. Clin. Oncol.. 2004 Dec 1; 22 (23) : 4804-9.
  Pubmed PMID: 15570082.
• Berg SL, Winick N, Ingle AM, Adamson PC, Blaney SM. " Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium study. " Pediatr Blood Cancer. 2010 Jul 15; 55 (1) : 119-22.
  Pubmed PMID: 20486176.
• Ryu RJ, Eyal S, Kaplan HG, Akbarzadeh A, Hays K, Puhl K, Easterling TR, Berg SL, Scorsone KA, Feldman EM, Umans JG, Miodovnik M, Hebert MF. " Pharmacokinetics of doxorubicin in pregnant women " Cancer Chemother Pharmacol. 2014 ; 73 : 789-797.
  Pubmed PMID: 24531558.
• Blaney SM, Tagen M, Onar-Thomas A, Berg SL, Gururangan S, Scorsone K, Su J, Goldman S, Kieran MW, Kun L, Boyett J, Stewart C. " A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study. " Pediatr Blood Cancer. 2013 Apr ; 60 (4) : 627-32.
  Pubmed PMID: 23002039.
• Muscal JA, Scorsone KA, Zhang L, Ecsedy JA, Berg SL. " Additive effects of vorinostat and MLN8237 in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines. " Invest New Drugs. 2013 Feb ; 31 (1) : 39-45.
  Pubmed PMID: 22669335.
• Berg SL, Poplack DG. " Advances in the treatment of meningeal cancers. " Crit. Rev. Oncol. Hematol.. 1995 Aug ; 20 (41276) : 87-98.
  Pubmed PMID: 7576199.